The Global Precision Medicine Market is poised for rapid expansion through 2032, fueled by breakthroughs in genomics, AI-powered diagnostics, and targeted therapeutics. Oncology leads applications, supported by biomarker-driven clinical trials and companion diagnostics, while digital health infrastructure grows fastest. North America dominates due to advanced healthcare systems, and A... https://www.uniprismmarketresearch.com/verticals/healthcare/precision-medicine